Exercise program for patients with pancreatic cancer

A Supervised Prehabilitation Program for Patients With Pancreatic Cancer

Not applicable Interventional Cedars-Sinai Medical Center · NCT05692323

This study tests whether a guided exercise program can help people with pancreatic cancer feel better and improve their health during treatment.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment16 (estimated)
Ages18 Years and up
SexAll
SponsorCedars-Sinai Medical Center Academic / other
Locations1 site (Los Angeles, California)
Trial IDNCT05692323 on ClinicalTrials.gov

What this trial studies

This study evaluates the effectiveness of a supervised exercise program for individuals diagnosed with pancreatic cancer. Participants will engage in exercise sessions three times a week for six weeks, with their attendance and health outcomes monitored throughout the program. The study aims to assess impacts on healthcare utilization, muscle mass, quality of life, physical activity levels, and post-operative outcomes when applicable. Participants will also use a Fitbit to track their activity and complete surveys and functional assessments at various time points.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18 and older with a diagnosis of pancreatic cancer who are physically able to participate in the exercise program.

Not a fit: Patients who are unable to ambulate independently or have severe comorbidities that prevent participation in physical activity may not benefit from this study.

Why it matters

Potential benefit: If successful, this program could enhance the physical well-being and quality of life for patients with pancreatic cancer.

How similar studies have performed: Other studies have shown positive outcomes with exercise interventions in cancer patients, suggesting potential success for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pancreatic cancer diagnosis (any stage)
* Age ≥ 18 years
* Independent ambulation and activities of daily living (Discretion of referring/ treating oncologist)
* Godin-Shephard Leisure-Time Physical Activity Questionnaire score of ≤ 23
* Physically able to complete functional assessments including 6-minute walk test, hand grip strength, short performance physical battery and performance metrics
* Answers no to all questions on PAR-Q OR is cleared to participate by their treating oncologist
* Ability to read, write and understand English
* Written informed consent obtained from subject and ability for subjects to comply with the requirements of the study

Inclusion criteria for remote monitoring of physical activity (Fitbit) and online Pain portal only (failure to meet inclusion criterion below should not preclude subjects from participating in main study):

* Access to a smart device capable of Fitbit syncing and accessing the online Pain portal (www.painguide.com)

Exclusion Criteria:

* Has undergone or plans to undergo resection surgery prior to projected completion of PREHAB exercise intervention
* Current pregnancy

Exclusion criteria for remote monitoring component of the study with Fitbit only (failure to meet exclusion criterion below should not preclude the subject from participating in main study):

* Using a pacemaker, implantable cardiac defibrillator, neurostimulator, cochlear implants (removable hearing aids permitted), or other electronic medical equipment, unless the PI deems study participation safe.

Where this trial is running

Los Angeles, California

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Pancreas CancerExercisePrehabilitation
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.